Overview
- Evonik and its anchor shareholder RAG‑Stiftung have both confirmed receiving an unsolicited, non‑binding takeover approach from BASF that was reported by multiple news outlets.
- BASF has not issued a formal comment and companies say active negotiations or a binding offer have not been disclosed.
- Evonik shares jumped by more than 8% on the takeover speculation while BASF shares fell, reflecting investor focus on deal risk and potential value changes.
- A purchase would be costly because Evonik’s market value is about €8–8.4 billion and a typical takeover would require a significant premium that BASF would need to finance.
- The approach is framed as a strategic bid to broaden BASF’s product range and regional scale to compete with Chinese suppliers, and the RAG‑Stiftung’s stance will be decisive for any deal and for Evonik’s ongoing restructuring plans.